{"product_id":"microbiome-therapeutics-global-markets","title":"Microbiome Therapeutics: Global Markets","description":"\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003e4d Pharma\u003cbr\u003e\nAo Biome Llc\u003cbr\u003e\nArmata Pharmaceuticals\u003cbr\u003e\nAssembly Biosciences Inc.\u003cbr\u003e\nAzitra Inc.\u003cbr\u003e\nBiomica\u003cbr\u003e\nBiomx\u003cbr\u003e\nChain Biotechnology Ltd.\u003cbr\u003e\nEligo Bioscience Sas\u003cbr\u003e\nEnterome Sa\u003cbr\u003e\nEvelo Biosciences\u003cbr\u003e\nFinch Therapeutics Group Inc.\u003cbr\u003e\nIntralytix Inc.\u003cbr\u003e\nMaat Pharma\u003cbr\u003e\nOsel Inc.\u003cbr\u003e\nPylum Biosciences Inc.\u003cbr\u003e\nQuorum Innovations Llc\u003cbr\u003e\nRebiotix Inc. (A Ferring Company)\u003cbr\u003e\nSecond Genome\u003cbr\u003e\nSenda Biosciences Inc.\u003cbr\u003e\nSeres Therapeutics Inc.\u003cbr\u003e\nSfa Therapeutics Inc.\u003cbr\u003e\nSynlogic\u003cbr\u003e\nTheriva Biologics Inc.\u003cbr\u003e\nVedanta Biosciences Inc.\u003cbr\u003e\nYsopia Bioscience Inc.Report Scope:\u003c\/p\u003e\n\n\u003cp\u003eBCC Research’s new report, Microbiome Therapeutics: Global Markets, provides a comprehensive analysis of the microbiome therapeutics market in global context, including market forecasts and sales through 2027. The report analyzes the market by segmenting it into the various types of microbiome therapeutics, based on the strategies used for treatment: additive (fecal matter transplants or FMTs, live biotherapeutic products or LBPs), modulatory (postbiotics, prebiotics) and subtractive microbiome therapeutics (phages and antimicrobials). This study surveys the microbiome therapeutics market by application or disease segment: infectious diseases, metabolic diseases, cancer, gut-brain axis, and others. The market is assessed in the following geographic regions: North America, Europe, and emerging markets. Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, and Latin America.\u003c\/p\u003e\n\n\u003cp\u003eThe report features leading clinical trials indicating the status and phase of development. New developments and patents are boosting growth of this market in the global context.\u003c\/p\u003e\n\n\u003cp\u003eThe new BCC report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on the changing market trends, market players and leading pipeline candidates. This chapter covers influential mergers and acquisitions and other collaborations or partnerships that happened during the evaluation period of this report.\u003c\/p\u003e\n\n\u003cp\u003eStrengths, weaknesses, threats, and opportunities that are expected to play a role in the microbiome therapeutics market are evaluated in detail.\u003c\/p\u003e\n\n\u003cp\u003eThe markets for prebiotics and probiotics labeled as nutritional or dietary supplements are excluded from this report. Prebiotics and probiotics are included when used in the context of microbiome therapy.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e32 data tables and 44 additional tables\u003c\/p\u003e\n\n\u003cp\u003eAn up-to-date overview and analysis of the global and regional markets for microbiome therapeutics\u003c\/p\u003e\n\n\u003cp\u003eAnalyses of the global market trends, with historic market revenue (sales data) for 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027\u003c\/p\u003e\n\n\u003cp\u003eDiscussion of the industry growth driving factors and major technology challenges and issues affecting the market for microbiome therapeutics as a basis for projecting demand over the next few years (2022-2027)\u003c\/p\u003e\n\n\u003cp\u003eEstimation of the actual market size and revenue forecast for global microbiome therapeutics market in USD million terms, and corresponding market share analysis by technology type, application, and region\u003c\/p\u003e\n\n\u003cp\u003eHighlights of this innovation driven market covering current trends in genome sequencing industry, disease areas of application, clinical trials and their stages, and recent breakthrough innovations etc.\u003c\/p\u003e\n\n\u003cp\u003eAssessment of the recent industry structure for microbiome therapeutics, ongoing research (R\u0026amp;D) activities, analysis of competitive environment, and the COVID-19 impact on the marketplace\u003c\/p\u003e\n\n\u003cp\u003eReview of the patents and patent applications on microbiome therapeutics, and related scientific publications during the analysis period\u003c\/p\u003e\n\n\u003cp\u003eCompetitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial updates, and market share analysis based on recent segmental revenues\u003c\/p\u003e\n\n\u003cp\u003eProfile description of the major market participants, including Assembly Biosciences, Finch Therapeutics, Second Genome, Evelo Biosciences, Ysopia Bioscience and Evelo Biosciences4D PHARMA\u003cbr\u003e\nAO BIOME LLC\u003cbr\u003e\nARMATA PHARMACEUTICALS\u003cbr\u003e\nASSEMBLY BIOSCIENCES INC.\u003cbr\u003e\nAZITRA INC.\u003cbr\u003e\nBIOMICA\u003cbr\u003e\nBIOMX\u003cbr\u003e\nCHAIN BIOTECHNOLOGY LTD.\u003cbr\u003e\nELIGO BIOSCIENCE SAS\u003cbr\u003e\nENTEROME SA\u003cbr\u003e\nEVELO BIOSCIENCES\u003cbr\u003e\nFINCH THERAPEUTICS GROUP INC.\u003cbr\u003e\nINTRALYTIX INC.\u003cbr\u003e\nMAAT PHARMA\u003cbr\u003e\nOSEL INC.\u003cbr\u003e\nPylum Biosciences Inc.\u003cbr\u003e\nQUORUM INNOVATIONS LLC\u003cbr\u003e\nRebiotix Inc. (a Ferring Company)\u003cbr\u003e\nSECOND GENOME\u003cbr\u003e\nSenda biosciences INC.\u003cbr\u003e\nSERES THERAPEUTICS INC.\u003cbr\u003e\nSFA THERAPEUTICS INC.\u003cbr\u003e\nSYNLOGIC\u003cbr\u003e\nTHERIVA Biologics Inc.\u003cbr\u003e\nVEDANTA BIOSCIENCES INC.\u003cbr\u003e\nYSOpia bioscience Inc.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 175 Pages \/ MCW16226879","offer_id":47640173445426,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/microbiome-therapeutics-global-markets","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}